Marcin Kowanetz - Senior Scientist, Oncology Biomarker Development (OBD)

Marcin Kowanetz

Senior Scientist, Oncology Biomarker Development (OBD)

"The biomarker work we do everyday here in OBD at Genentech potentially impacts drug development as well as future patients’ care. It can’t get more rewarding and exciting than that!"
Years at Genentech
Awards & Honors

I obtained a MSc degree in Biotechnology from Jagiellonian University in Krakow, Poland and a PhD degree in Molecular and Cellular Biology from Ludwig Institute for Cancer Research in Uppsala, Sweden.

Subsequently, I was fortunate enough to join Genentech as a post-doctoral fellow in Dr. Napoleone Ferrara’s group in Research in 2005 to study a role of myeloid cells in tumorgenesis/metastasis. In 2010, I joined the Oncology Biomarker Development group as a biomarker scientist, drawn by an exciting opportunity to do biomarker research on samples from cancer patients and to make a direct impact on personalized health care. As a Biomarker lead in Cancer Immunotherapy Biomarkers, I lead identification and development of biomarkers for anti-PDL1 in patients with various types of lung cancer.

Featured Publication

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.

Nature. 2014 Nov 27;515(7528):563-7.

Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, Sosman JA, McDermott DF, Powderly JD, Gettinger SN, Kohrt HE, Horn L, Lawrence DP, Rost S, Leabman M, Xiao Y, Mokatrin A, Koeppen H, Hegde PS, Mellman I, Chen DS, Hodi FS.